Form S-3 TScan Therapeutics, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Wall Street rallies as chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices dive by more than 2% as inflation fears outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
TScan Therapeutics, Inc (TCRX) Files $300M Mixed Shelf
March 5, 2025 4:28 PM ESTTScan Therapeutics, Inc (NASDAQ: TCRX) has filed $300,000,000 mixed shelf of:
Voting Common Stock
Non-Voting Common Stock
Preferred Stock
Debt Securities
Warrants
Units
... More